Atorvastatin and sildenafil decrease vascular TGF-beta levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension

作者：Guimaraes Danielle A; Rizzi Elen; Ceron Carla S; Martins Oliveira Alisson; Gerlach Raquel F; Shiva Sruti; Tanus Santos Jose E^*

来源：Redox Biology, 2015, 6: 386-395.

DOI：10.1016/j.redox.2015.08.017

• Atorvastatin
• Hypertension
• Matrix metalloproteinase
• Sildenafil

Imbalanced matrix metalloproteinase (MMP)-2 activity and transforming growth factor expression (TGF-beta) are involved in vascular remodeling of hypertension. Atorvastatin and sildenafil exert antioxidant and pleiotropic effects that may result in cardiovascular protection. We hypothesized that atorvastatin and sildenafil alone or in association exert antiproliferative effects by down regulating MMP-2 and TGF-beta, thus reducing the vascular hypertrophy induced by two kidney, one clip (2K1C) hypertension. Sham and 2K1C rats were treated with oral atorvastatin 50 mg/kg, sildenafil 45 mg/kg, or both, daily for 8 weeks. Blood pressure was monitored weekly. Morphologic changes in the aortas were studied. TGF-beta levels were determined by immunofluorescence. MMP-2 activity and expression were determined by in situ zyrnography, gel zyrnography, Western blotting, and immunofluorescence. The effects of both drugs on proliferative responses of aortic smooth muscle cells to PDGF and on on MMP-2 activity in vitro were determined. Atorvastatin, sidenafil, or both drugs exerted antiproliferative effects in vitro. All treatments attenuated 2K1C-induced hypertension and prevented the increases in the aortic cross-sectional area and media/lumen ratio in 2K1C rats, Aortas from 2K1C rats showed higher collagen deposition, TGF-beta levels and MMP-2 activity and expression when compared with Sham-operated animals. Treatment with atorvastatin and/or sildenafil was associated with attenuation of 2K1C hypertension-induced increases in these pro-fibrotic factors. However, these drugs had no in vitro effects on hr-MMP-2 activity. Atorvastatin and sildenafil was associated with decreased vascular TGF-beta levels and MMP-2 activity in renovascular hypertensive rats, thus ameliorating the vascular remodeling. These novel pleiotropic effects of both drugs may translate into protective effects in patients.

• 出版日期2015-12